INCR
InterCure Ltd.
Healthcare · Drug Manufacturers - Specialty & Generic · NGM
$1.02
Data: 2026-05-19
✓ ETHICAL PASS
MOAT
HIGH
Data Confidence: 100.0%
Key Metrics
How this company measures up on the fundamentals that matter
Market Cap
$45M
Total market value of the company
0.00
Rev Growth
+23.9%
Year-over-year revenue change
Profit Margin
-13.2%
How much profit the company keeps from each dollar of revenue
Analyst Target
N/A
Recommendation
N/A
Consensus view from ? analysts covering this stock
About InterCure Ltd.
Company description not available.
Ethical Screening
Five compliance checks based on AAOIFI standards — all must pass for ethical clearance
Business Activity
PASS
Core business does not involve prohibited activities
Debt Ratio
0.0% PASS
Debt must be below 33% of total assets
Cash Ratio
0.0% PASS
Interest-bearing cash below 33% of assets
Receivables
0.0% PASS
Receivables below 49% of assets
Revenue Purity
0.0% PASS
Non-compliant revenue below 5% — any excess requires purification
Quantitative Intelligence
Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data
Annual Return
-47.7%
Historical annualised return based on price data
Days in State
16
How long the current regime has persisted — longer means more stable
Market Data
Trading characteristics and market positioning
N/A
52W High
$N/A
52W Low
$N/A
Avg Volume
N/A
Average daily shares traded — higher means easier to buy and sell
Short % Float
N/A
Financial Health
Balance sheet strength and cash generation — the foundation of long-term value
Quick Ratio
N/A
Like current ratio but excludes inventory — stricter test
Gross Margin
N/A
Revenue left after cost of goods — higher means pricing power
Operating Margin
N/A
Profit from core operations before interest and tax
Revenue (TTM)
N/A
Total revenue over the last 12 months
Net Income
N/A
Loss-making — spending exceeds revenue after all costs
Recent Insider Activity
SEC Form 4 filings — what company insiders are buying and selling
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2022-03-23 | Fegel (Yael) | 10% Security Holder of Issuer | 1,823 | $41,382 | |
| 2022-03-22 | Fegel (Yael) | 10% Security Holder of Issuer | 100,000 | $2,285,000 | |
| 2022-03-21 | Fegel (Yael) | 10% Security Holder of Issuer | 48,362 | $1,088,145 | |
| 2022-03-16 | Fegel (Yael) | 10% Security Holder of Issuer | 1,224 | $25,826 | |
| 2022-03-15 | Fegel (Yael) | 10% Security Holder of Issuer | 3,000 | $63,239 | |
| 2022-03-15 | Fegel (Yael) | 10% Security Holder of Issuer | 6,000 | $127,439 | |
| 2022-03-15 | Fegel (Yael) | 10% Security Holder of Issuer | 10,000 | $210,600 |
Source: SEC Form 4 filings via public data. View all insider activity at
Insider Intelligence
Political Trading Activity
Congressional trading disclosures involving this instrument
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 26 Feb2025 | Daniel Webster | Republican | sell | 15K–50K |
| 2026-04-13 | Ro Khanna | Democrat | Purchase | 1K–15K |
Source: Congressional disclosure filings. View all political trades at
Insider Intelligence
Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-19